Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle Children’s, and UW Medicine complete restructuring of partnership

Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings

In the 1970s, when E. Donnall Thomas was researching bone marrow transplantation, Fred Hutchinson Cancer Center started a database of transplant recipients.

April 11, 2025

Vol.51 No.14

In Brief

Filippo Milano named inaugural Endowed Chair in Cord Blood Research at Fred Hutch

Filippo Milano, a hematologist-oncologist and clinical researcher, was named the inaugural Endowed Chair in Cord Blood Research at Fred Hutchinson Cancer Center.

April 11, 2025

Vol.51 No.14

In the Archives

Fred Hutch marks “50 years of doing hard things”

This year, Fred Hutch Cancer Center celebrates its 50th anniversary. Fred Hutch will be marking this milestone with a series of historical articles, a timeline, photo archives, and more as the year progresses.

March 07, 2025

Vol.51 No.09

In Brief

Fred Hutch announces 10 recipients of the annual Harold M. Weintraub Graduate Student Award

Fred Hutch Cancer Center announced 10 recipients of the annual Harold M. Weintraub Graduate Student Award, which recognizes the exceptional achievements of graduate studies in the biological sciences.

March 07, 2025

Vol.51 No.09

Clinical Roundup

New biomarker can predict cancer aggressiveness, study finds

Researchers from Fred Hutch Cancer Center and the University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers using a new technology and computational method.

February 21, 2025

Vol.51 No.07

Drugs & Targets

Dewpoint Therapeutics and ConcertAI form drug development partnership

Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s latest drug candidate, DPTX3186.

December 13, 2024

Vol.50 No.46